Targeted inhibition of the COP9 signalosome for treatment of cancer
2016 · Nature Communications · 196 citations
https://doi.org/10.1038/ncomms13166
M
Martin Renatus
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
6.3K
Citations
31
h-index
40
i10-index
Martin Renatus is an academic researcher. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Cell death mechanisms and regulation & Peptidase Inhibition and Analysis. The author has an h-index of 31, co-authored 72 publications.
ORCID: 0000-0002-7348-2915Papers by this author
worksDCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
2024 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-023-44237-4
Structural Basis of BRCC36 Function in DNA Repair and Immune Regulation
2019 · Molecular Cell · 73 citations
https://doi.org/10.1016/j.molcel.2019.06.002
Hormone-mediated disassembly and inactivation of a plant E3 ubiquitin ligase complex
2024 · Cell Reports · 5 citations
https://doi.org/10.1016/j.celrep.2024.114802
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
2024 · Nature Communications · 1 citations
https://doi.org/10.1038/s41467-024-51317-6
Fragment-based discovery enables direct targeting of the melanoma oncogene MITF
2025 · Nature Communications · 0 citations
https://doi.org/10.1038/s41467-025-67297-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat